الفهرس 
Chronic kidney diseaseOnly 14 pages are availabe for public view
 |  | from | 151 |  |  |
| | | from | 151 | | |
Abstract
In patients with CKD, dyslipidemia is a very common complication; disturbances in lipid metabolism are seen even at the early stages of CKD and subsequently progress with the deterioration of renal function.
Serum magnesium level may be elevated, normal or decreased in CKD patients. These alterations of magnesium balance increase with the advanced stages of CKD.
Data have shown a correlation between serum magnesium concentration and dyslipidemia in CKD patients by altering lipid metabolism and these alterations might contribute to the dramatic increase in cardiovascular events and mortality observed in the CKD population.
So, this study was conducted to assess the association between serum Mg level and lipid parameters in CKD patients with stage 4, stage 5 predialysis and stage 5 on hemodialysis.